Boundless Bio IPO

boundlessbio.com

Boundless Bio enables the companies researchers to interrogate ecDNA biology and maintain a robust pipeline of novel oncology targets essential to the function of cancer cells that are enabled by ecDNA.

Founded2018
Total Funding to Date$152.05MM
Register for Details

For more details on financing and valuation for Boundless Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Boundless Bio Ticker Symbol

Boundless Bio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Boundless Bio Stock Price

The stock price for Boundless Bio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Boundless Bio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/28/2021 Series B $262.52MM $XXX.XX $XXX.XX
9/19/2019 Series A $103.26MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Boundless Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM